1. Histone deacetylase inhibitor chidamide regulates the Wnt/β-catenin pathway by MYCN/DKK3 in B-ALL
   Linlin Zhao et al, 2021, Investigational New Drugs CrossRef
2. Advances in Epigenetic Cancer Therapeutics
   Christopher Hillyar et al, 2020, Cureus CrossRef
3. Therapeutic Interaction of Apatinib and Chidamide in T-Cell Acute Lymphoblastic Leukemia through Interference with Mitochondria Associated Biogenesis and Intrinsic Apoptosis
   Mengya Zhong et al, 2021, Journal of Personalized Medicine CrossRef
4. Chidamide Suppresses the Growth of Cholangiocarcinoma by Inhibiting HDAC3 and Promoting FOXO1 Acetylation
   Yongpan Li et al, 2022, Stem Cells International CrossRef
5. Chidamide: Targeting epigenetic regulation in the treatment of hematological malignancy
   Han‐Yu Cao et al, 2023, Hematological Oncology CrossRef